New combo attack on tough pancreatic tumors
NCT ID NCT02207465
Summary
This early-stage study is testing whether combining a chemotherapy drug (nab-paclitaxel) with higher doses of radiation can better control pancreatic cancer that is difficult or impossible to remove with surgery. The goal is to see if this more intense treatment is safe and can shrink tumors to improve survival. The study involves 42 adults with specific types of advanced pancreatic cancer who have not had prior treatment for it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Chester County Hospital
West Chester, Pennsylvania, 19380, United States
Conditions
Explore the condition pages connected to this study.